Paz-Ares, Luis and Schulz, Christian (2022) Durvalumab +/- tremelimumab plus platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): 36-monthoverall survival from the Phase 3 CASPIAN study. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.
Full text not available from this repository.
Official URL: https://karger.com/ort/issue/45/Suppl.%203
| Item Type: | Conference or Workshop Item (Poster) |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Petra Gürster |
| Date Deposited: | 11 Oct 2023 09:15 |
| Last Modified: | 11 Oct 2023 09:15 |
| URI: | https://pred.uni-regensburg.de/id/eprint/57089 |
Actions (login required)
 |
View Item |
